How implementing electronic clinical outcome assessments (eCOA) into Oncology Clinical Trials Reduces the Burden...
Clinical oncology research is unique when compared to other therapeutic areas. Cancer patients experience substantial...
AstraZeneca provides update on the Phase III MYSTIC trial of Imfinzi and tremelimumab in...
AstraZeneca and MedImmune, its global biologics research and development arm, announced final overall survival (OS)...
Pharm-Olam is proud to have contributed to the execution and completion of Cablivi ivotal...
Pharm-Olam, a global, midsized CRO offering full-service clinical development solutions for oncology, infectious diseases and...
REGENXBIO Announces Additional Positive Interim Phase I Trial Update for RGX-314
REGENXBIO Inc. a leading clinical-stage biotechnology company seeking to improve lives through the curative potential...
Quotient Sciences Constructs State-of-the-Art Early-Phase Formulation and Manufacturing Facility in U.S.
Quotient Sciences, a leading drug development services organization, announces a significant expansion to its operations...
Eisai and Purdue Pharma Announce Positive Topline Results of SUNRISE 2, the Second Phase...
Eisai Co., Ltd. and Purdue Pharma L.P. announced positive topline results from SUNRISE 2, a...
GamaMabs Pharma starts a phase 2 study of monoclonal antibody GM102 in patients with...
GamaMabs Pharma, a biotechnology company developing optimized therapeutic antibodies targeting the Anti-Müllerian Hormone Receptor II...
Thrombolytic Science Initiates Phase 2 Clinical Trial of its Novel Treatment Regimen for Ischemic...
Thrombolytic Science, LLC (TSI) today announced initiation of a Phase 2 clinical trial to confirm...
CRF Health Partners Innovative US Biotech with TrialMax® eCOA Solution for Phase III Prostate...
CRF Health, the leading provider of patient-centered eSource technology solutions for the life sciences industry,...
Celtaxsys Announces Results of Phase 2 Trial Showing Clinically Meaningful Improvement in Pulmonary Exacerbations...
Celtaxsys, Inc., a clinical stage pharmaceutical development company focused on advancing treatments for patients with...
